Grown Rogue International (GRUSF) EPS (Basic) (2009 - 2026)

Grown Rogue International (GRUSF) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, up 100.0% quarter-over-quarter from -$26672.4 in Q4 2025.

Grown Rogue International (GRUSF) EPS (Basic) (2009 - 2026) Analysis & Trends

Grown Rogue International's EPS (Basic) history runs 18 years deep, the most recent figure standing at -$0.0 for Q1 2026.

In Q1 2026, EPS (Basic) changed N/A year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$15185.2 (down 55583853.75% YoY), while the FY2025 annual figure was -$0.0, down 75.84% from the prior year.
EPS (Basic) for Q1 2026 stood at -$0.0, up from -$26672.4 in the prior quarter.
The five-year high for EPS (Basic) was $10812.4 in Q3 2025, with the low at -$26672.4 in Q4 2025.
The 5-year median for EPS (Basic) is -$0.0 (2026), against an average of -$1441.8.
The sharpest annual moves came in 2022 and 2025: EPS (Basic) soared 74.28% in 2022, then jumped 408607113.45% in 2025.
Grown Rogue International's EPS (Basic) stood at -$0.0 in 2022, then surged by 222.57% to $0.0 in 2023, then sank by 184.23% to -$0.0 in 2024, then slumped by 1007963856.95% to -$26672.4 in 2025, then soared by 100.0% to -$0.0 in 2026.
Business Quant data shows GRUSF's EPS (Basic) at -$0.0 in Q1 2026, -$26672.4 in Q4 2025, and $10812.4 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn	-0.49
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn	2.07
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	0.45
5	United Therapeutics	22.19 Bn	19.53 Bn	683.80 Mn	7.82
6	Viatris	18.68 Bn	17.79 Bn	1.46 Bn	-0.10
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	1.43
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	0.11
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Grown Rogue International	110.47 Mn	98.93 Mn	5.37 Mn	-0.01

Download Data